Industry News
Rayner Announces Launch of "World’s First Spiral IOL Designed with AI"
Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, recently announced the upcoming launch of RayOne Galaxy and Galaxy Toric which is according to the company the world’s first spiral intraocular lens (IOL) designed with artificial intelligence (AI).
Launching at this year’s European Society of Cataract and Refractive Surgeons (ESCRS) Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the very first IOL with Sir Harold Ridley, a milestone being celebrated throughout 2024. As in 1949, Rayner has partnered with a leading ophthalmologist, Dr João Lyra from Brazil, to develop this innovative full range of vision IOL.
Unlike in 1949, a proprietary AI engine trained on patient outcomes has been utilised to help create RayOne Galaxy’s unique spiral, which delivers a continuous full range of vision with minimised dysphotopsia, achieved through a non-diffractive optic with 0% light loss. RayOne Galaxy will be available immediately in toric powers and comes fully preloaded across the entire power range in the same single-use injector system as the rest of the popular RayOne family of lenses.
Tim Clover, Rayner CEO, said: “We all read about the life changing potential of AI, but this is a real-world example of technology impacting the outcomes of patients. RayOne Galaxy represents a next generation technology in intraocular lenses to enable patients to see without spectacles. Launching the world’s first spiral optic lens on the 75th anniversary of the world’s first IOL feels poetic and I’m proud that Rayner is still at the forefront of technology, partnering with innovative surgeons from all over the world and making a difference to the life of millions of patients every year.”
Clinical investigations with RayOne Galaxy began earlier this year, in collaboration with 8 leading surgeons from around the world and key research labs in Europe and Brazil. Many of those surgeons are due to present their initial findings at the ESCRS 2024 meeting in September, at Rayner’s highly anticipated Sunday lunchtime symposium.
Mr Allon Barsam, Consultant Ophthalmic Surgeon and Director at OCL Vision in London, explained: “The first patients received RayOne Galaxy at OCL Vision in July and their feedback so far has been overwhelmingly positive, with patients reading without glasses and thrilled with their quality of vision. I am proud to be participating in the first RayOne Galaxy study to provide my patients with the most advanced lens technology.”
